Dr Jean-Jacques Kiladjian at ASH 2014: Molecular profile of malignant clones in response to therapy in JAK2V617F-negative essential thrombocythaemia - 101271

Spotlight
Video

Dr Jean-Jacques Kiladjian at ASH 2014: Molecular profile of malignant clones in response to therapy in JAK2V617F-negative essential thrombocythaemia

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Jean-Jacques Kiladjian (Hôpital Saint-Louis & Université Paris Diderot, Paris, France) discusses using a next-generation sequencing approach to assess the mutational patterns of prognostically-relevant mutations (previously identified in myeloproliferative neoplasms) in calreticulin gene-mutated essential thrombocythaemia (ET) patients during interferon alpha (IFN-α) therapy.
Shared By : EMJ
Posted on : 01/09/15
Added : 3 years ago